NCT05428397View on ClinicalTrials.gov

A Study, Called UV Population, to Learn More About the Safety of the Study Drug Ultravist, Which is Given to Get Clearer X-ray Pictures, in People of Different Sexes, Races, and From Different Countries/Regions

CompletedOBSERVATIONAL
Enrollment

152,233

Participants

Timeline

Start Date

June 30, 2022

Primary Completion Date

October 28, 2022

Study Completion Date

October 28, 2022

Conditions
Contrast Enhanced X-ray Based Examination
Interventions
DIAGNOSTIC_TEST

Iopromide (Ultravist, BAY86-4877)

X-Ray/CT Diagnostic Imaging

Trial Locations (1)

42096

Bayer, Wuppertal

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT05428397 - A Study, Called UV Population, to Learn More About the Safety of the Study Drug Ultravist, Which is Given to Get Clearer X-ray Pictures, in People of Different Sexes, Races, and From Different Countries/Regions | Biotech Hunter | Biotech Hunter